196 related articles for article (PubMed ID: 17511006)
1. Synthesis, cytotoxicity, and antitumor activity of lantadene-A congeners.
Sharma M; Sharma PD; Bansal MP; Singh J
Chem Biodivers; 2007 May; 4(5):932-9. PubMed ID: 17511006
[TBL] [Abstract][Full Text] [Related]
2. Lantadenes and their esters as potential antitumor agents.
Sharma M; Sharma PD; Bansal MP
J Nat Prod; 2008 Jul; 71(7):1222-7. PubMed ID: 18553923
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of lantadene A congener with hydroxyl functionality in ring A as an antitumour agent.
Sharma M; Rakhi A; Dalal N; Sharma N
Nat Prod Res; 2011 Feb; 25(4):387-96. PubMed ID: 20623424
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro anticancer studies of novel C-2 arylidene congeners of lantadenes.
Tailor NK; Boon HL; Sharma M
Eur J Med Chem; 2013 Jun; 64():285-91. PubMed ID: 23644211
[TBL] [Abstract][Full Text] [Related]
5. Cancer chemopreventive activity of lupane- and oleanane-type triterpenoids from the cones of Liquidamber styraciflua.
Fukuda Y; Sakai K; Matsunaga S; Tokuda H; Tanaka R
Chem Biodivers; 2005 Mar; 2(3):421-8. PubMed ID: 17191990
[TBL] [Abstract][Full Text] [Related]
6. Relative inhibitory activity of bile acids against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation, and chenodeoxycholic acid inhibition of tumour promotion in mouse skin two-stage carcinogenesis.
Yasukawa K; Iida T; Fujimoto Y
J Pharm Pharmacol; 2009 Aug; 61(8):1051-6. PubMed ID: 19703349
[TBL] [Abstract][Full Text] [Related]
7. Chemopreventive activity of lantadenes on two-stage carcinogenesis model in Swiss albino mice: AP-1 (c-jun), NFkappaB (p65) and P53 expression by ELISA and immunohistochemical localization.
Kaur J; Sharma M; Sharma PD; Bansal MP
Mol Cell Biochem; 2008 Jul; 314(1-2):1-8. PubMed ID: 18425423
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-human hepatocellular carcinoma activity of new nitric oxide-releasing glycosyl derivatives of oleanolic acid.
Huang Z; Zhang Y; Zhao L; Jing Y; Lai Y; Zhang L; Guo Q; Yuan S; Zhang J; Chen L; Peng S; Tian J
Org Biomol Chem; 2010 Feb; 8(3):632-9. PubMed ID: 20090981
[TBL] [Abstract][Full Text] [Related]
9. Boc-lysinated-betulonic acid: a potent, anti-prostate cancer agent.
Saxena BB; Zhu L; Hao M; Kisilis E; Katdare M; Oktem O; Bomshteyn A; Rathnam P
Bioorg Med Chem; 2006 Sep; 14(18):6349-58. PubMed ID: 16777417
[TBL] [Abstract][Full Text] [Related]
10. Potential O-acyl-substituted (-)-Epicatechin gallate prodrugs as inhibitors of DMBA/TPA-induced squamous cell carcinoma of skin in Swiss albino mice.
Vyas S; Manon B; Vir Singh T; Dev Sharma P; Sharma M
Chem Biodivers; 2011 Apr; 8(4):599-613. PubMed ID: 21480506
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of lantadene analogs with marked in vitro inhibition of lung adenocarcinoma and TNF-α induced nuclear factor-kappa B (NF-κB) activation.
Monika ; Sharma A; Suthar SK; Aggarwal V; Lee HB; Sharma M
Bioorg Med Chem Lett; 2014 Aug; 24(16):3814-8. PubMed ID: 25027934
[TBL] [Abstract][Full Text] [Related]
12. Biotransformation of lantadene A (22 beta-angeloyloxy-3-oxoolean-12-en-28-oic acid), the pentacyclic triterpenoid, by Alcaligenes faecalis.
Singh A; Sharma OP; Dawra RK; Kanwar SS; Mahato SB
Biodegradation; 1999; 10(5):373-81. PubMed ID: 10870553
[TBL] [Abstract][Full Text] [Related]
13. Cancer chemopreventive activity of 3beta-methoxyserrat-14-en-21beta-ol and several serratane analogs on two-stage mouse skin carcinogenesis.
Tanaka R; Shanmugasundaram K; Yamaguchi C; Ishikawa Y; Tokuda H; Nishide K; Node M
Cancer Lett; 2004 Oct; 214(2):149-56. PubMed ID: 15363540
[TBL] [Abstract][Full Text] [Related]
14. A novel synthetic oleanolic acid derivative with amino acid conjugate suppresses tumour growth by inducing cell cycle arrest.
Lu XM; Yi HW; Xu JL; Sun Y; Li JX; Cao SX; Xu Q
J Pharm Pharmacol; 2007 Aug; 59(8):1087-93. PubMed ID: 17725850
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of ferulic acid on 7,12-dimethylbenz[a]anthracene-induced skin carcinogenesis in Swiss albino mice.
Alias LM; Manoharan S; Vellaichamy L; Balakrishnan S; Ramachandran CR
Exp Toxicol Pathol; 2009 May; 61(3):205-14. PubMed ID: 18845425
[TBL] [Abstract][Full Text] [Related]
16. Structure determination of inonotsuoxides A and B and in vivo anti-tumor promoting activity of inotodiol from the sclerotia of Inonotus obliquus.
Nakata T; Yamada T; Taji S; Ohishi H; Wada S; Tokuda H; Sakuma K; Tanaka R
Bioorg Med Chem; 2007 Jan; 15(1):257-64. PubMed ID: 17049251
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor activity of a 3-oxo derivative of oleanolic acid.
Huang D; Ding Y; Li Y; Zhang W; Fang W; Chen X
Cancer Lett; 2006 Feb; 233(2):289-96. PubMed ID: 16154686
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxicity evaluation of oleanolic acid derivatives.
Hao J; Liu J; Wen X; Sun H
Bioorg Med Chem Lett; 2013 Apr; 23(7):2074-7. PubMed ID: 23434227
[TBL] [Abstract][Full Text] [Related]
19. Efficient synthesis of (-)- and (+)-tricyclic compounds with enone functionalities in rings A and C. A novel class of orally active anti-inflammatory and cancer chemopreventive agents.
Honda T; Favaloro FG; Janosik T; Honda Y; Suh N; Sporn MB; Gribble GW
Org Biomol Chem; 2003 Dec; 1(24):4384-91. PubMed ID: 14685310
[TBL] [Abstract][Full Text] [Related]
20. Synthetic cinnamylphenol derivatives as cancer chemopreventive agents.
Ito C; Itoigawa M; Kanematsu T; Imamura Y; Tokuda H; Nishino H; Furukawa H
Eur J Med Chem; 2007 Jul; 42(7):902-9. PubMed ID: 17316910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
